Alzheimer Disease and Related Dementia Following Hormone-Modulating Therapy in Patients With Breast Cancer
Explore this paper's citation graph
Summary
The results suggest that the association of HMT and ADRD varies by age and race; when deciding on breast cancer treatment, therapy and individual factors must be considered.
- Type
- article
- Published
- 2024-07-01
- Cited by
- 7
- References
- 45
- Access
- Open access
- OpenAlex
- https://openalex.org/W4400682691
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:271216562
Keywords
Medicine, Breast cancer, Dementia, Disease, Internal medicine
References
- Use of SEER-Medicare Data for Measuring Cancer Surgery
- The implications of propensity score variable selection strategies in pharmacoepidemiology – an empirical illustration
- Neurodegeneration: Potential Causes, Prevention, and Future Treatment Options
- Nationwide Study of Breast Cancer Risk Factors in Latinas
- Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes
- Estrogen plus progestin and the incidence of dementia and mild cognitive impairment in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
- An Introduction to Propensity Score Methods for Reducing the Effects of Confounding in Observational Studies
- Practical considerations on the use of the Charlson comorbidity index with administrative data bases.
- Alzheimer disease in the United States (2010–2050) estimated using the 2010 census
- ‘Hormonal’ risk factors, ‘breast tissue age’ and the age-incidence of breast cancer
- The Women’s Health Initiative Hormone Therapy Trials: Update and Overview of Health Outcomes During the Intervention and Post-Stopping Phases
- Effect of raloxifene on prevention of dementia and cognitive impairment in older women: the Multiple Outcomes of Raloxifene Evaluation (MORE) randomized trial.
- Marginal Structural Models as a Tool for Standardization
- Immortal time bias in pharmaco-epidemiology.
- Postmenopausal hormone therapy and Alzheimer’s disease risk: interaction with age
- Propensity Score Methods for Confounding Control in Non-Experimental Research
- Long-term use of tamoxifen reduces the risk of dementia: a nationwide population-based cohort study.
- A comparison of the recording of comorbidity in primary and secondary care by using the Charlson Index to predict short-term and long-term survival in a routine linked data cohort
- Statistical primer: propensity score matching and its alternatives†
- Overview of Breast Cancer Therapy
Cited by
- Physical Health Decline After Chemotherapy or Endocrine Therapy in Breast Cancer Survivors
- The risk of dementia in breast cancer survivors: a meta-analysis of observational studies
- Cardiovascular contributions to dementia: Examining sex differences and female‐specific factors
- Disentangling the inverse relationship between cancer and Alzheimer’s or Parkinson’s disease: A systematic review on Mendelian randomization studies
- Selective oestrogen receptor modulators and Alzheimer´s disease: a real-world pharmacovigilance study
- Women’s midlife: the front line of Alzheimer prevention
Related papers
- Evaluating the role of confounding in pharmacoeconomic studies.
- [The incidence of reversible dementia in 145 patients referred on suspicion of dementia].
- When Memory Fails: Helping the Alzheimer's and Dementia Patient
- Confounding Effect in Clinical Research of Otolaryngology and Its Control.
- Birthweight and blood pressure in five European birth cohort studies: an investigation of confounding factors.
- Inhaled corticosteroids in chronic obstructive pulmonary disease: results from two observational designs free of immortal time bias.
- Use of the General Practice Research Database (GPRD) for respiratory epidemiology: a comparison with the 4th Morbidity Survey in General Practice (MSGP4)